Resistance diagnosis and the changing economics of antibiotic discovery.
Publication
, Journal Article
McAdams, D
Published in: Annals of the New York Academy of Sciences
January 2017
Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the quantity of antibiotics sold. Advances in the science and technology underpinning rapid resistance diagnostics can therefore be expected to spur efforts to discover and develop new antibiotics, especially those with a narrow spectrum of activity that would otherwise fail to find a market.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Annals of the New York Academy of Sciences
DOI
EISSN
1749-6632
ISSN
0077-8923
Publication Date
January 2017
Volume
1388
Issue
1
Start / End Page
18 / 25
Related Subject Headings
- Humans
- General Science & Technology
- Drug Resistance, Bacterial
- Drug Discovery
- Costs and Cost Analysis
- Bacterial Infections
- Anti-Bacterial Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
McAdams, D. (2017). Resistance diagnosis and the changing economics of antibiotic discovery. Annals of the New York Academy of Sciences, 1388(1), 18–25. https://doi.org/10.1111/nyas.13303
McAdams, David. “Resistance diagnosis and the changing economics of antibiotic discovery.” Annals of the New York Academy of Sciences 1388, no. 1 (January 2017): 18–25. https://doi.org/10.1111/nyas.13303.
McAdams D. Resistance diagnosis and the changing economics of antibiotic discovery. Annals of the New York Academy of Sciences. 2017 Jan;1388(1):18–25.
McAdams, David. “Resistance diagnosis and the changing economics of antibiotic discovery.” Annals of the New York Academy of Sciences, vol. 1388, no. 1, Jan. 2017, pp. 18–25. Epmc, doi:10.1111/nyas.13303.
McAdams D. Resistance diagnosis and the changing economics of antibiotic discovery. Annals of the New York Academy of Sciences. 2017 Jan;1388(1):18–25.
Published In
Annals of the New York Academy of Sciences
DOI
EISSN
1749-6632
ISSN
0077-8923
Publication Date
January 2017
Volume
1388
Issue
1
Start / End Page
18 / 25
Related Subject Headings
- Humans
- General Science & Technology
- Drug Resistance, Bacterial
- Drug Discovery
- Costs and Cost Analysis
- Bacterial Infections
- Anti-Bacterial Agents